Drug Shortage Report for FENTANYL CITRATE INJECTION, USP

Last updated on 2024-07-10 History
Report ID 232398
Drug Identification Number 02501554
Brand name FENTANYL CITRATE INJECTION, USP
Common or Proper name FENTANYL CITRATE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR EPIDURAL
Packaging size 2 mL
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-07-09
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-07-10
Company comments Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Fentanyl Citrate Injection, USP 50 mcg/mL SD Vial 2 mL effective July 9, 2024, until August 30, 2024.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-07-10 English Compare
v2 2024-07-05 French Compare
v1 2024-07-05 English Compare

Showing 1 to 3 of 3